Contact Ipamorelin Doctor.
For editorial questions and corrections about our coverage of the ipamorelin literature.
Editorial and corrections
This desk is a telemetry-style reading of the published ipamorelin research. Use the form below for editorial inquiries — questions about how a study was summarized, requests to correct a citation, or notes about literature you think was missed. Every message is read, and the site is updated when a correction is warranted.
What this desk cannot do is anything clinical or commercial. There is no clinician on staff to answer a personal health question, and nothing here diagnoses, treats, or recommends; a health question belongs with a licensed healthcare professional. Nothing is sold, sourced, supplied, or brokered either, so purchasing, pricing, and sourcing inquiries can't be answered.
What to expect
Because this is a small editorial project rather than a company, responses are not immediate, and we prioritize substantive corrections to the published literature summaries. If you are flagging a broken citation or a misread study, please include the page, the specific claim, and the source you believe is correct — that makes it far faster for us to verify and fix. Messages seeking medical guidance, dosing help, or product purchases will not receive a substantive reply, because those fall outside what a reading desk like this can responsibly do.
The most useful correction we can receive is a pointer to primary literature we have either misread or missed — a study whose dose, species, or endpoint we summarized incorrectly, or a relevant trial we did not cite. Because the ipamorelin literature is small, individual studies carry real weight, and we would rather fix one citation properly than leave a single number unsupported. We do not, however, accept submissions for paid placement, link insertion, or sponsored content of any kind; the references list is curated from the published record alone.